ATRA
Price
$0.70
Change
+$0.04 (+6.06%)
Updated
Mar 27, 6:59 PM EST
41 days until earnings call
XNCR
Price
$22.42
Change
+$0.89 (+4.13%)
Updated
Mar 27, 6:59 PM EST
42 days until earnings call
Ad is loading...

Compare predictions ATRA vs XNCR

Header iconATRA vs XNCR Comparison
Open Charts ATRA vs XNCRBanner chart's image
Atara Biotherapeutics
Price$0.70
Change+$0.04 (+6.06%)
Volume$652.27K
CapitalizationN/A
Xencor
Price$22.42
Change+$0.89 (+4.13%)
Volume$253.18K
CapitalizationN/A
View a ticker or compare two or three
ATRA vs XNCR Comparison Chart

Loading...

ATRADaily Signal changed days agoGain/Loss if shorted
 
Show more...
XNCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ATRA vs. XNCR commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Buy and XNCR is a Buy.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (ATRA: $0.70 vs. XNCR: $22.43)
Brand notoriety: ATRA and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 32% vs. XNCR: 51%
Market capitalization -- ATRA: $71.35M vs. XNCR: $1.37B
ATRA [@Biotechnology] is valued at $71.35M. XNCR’s [@Biotechnology] market capitalization is $1.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • ATRA’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than ATRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • ATRA’s TA Score: 5 bullish, 4 bearish.
  • XNCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ATRA and XNCR are a good buy in the short-term.

Price Growth

ATRA (@Biotechnology) experienced а -2.78% price change this week, while XNCR (@Biotechnology) price change was -1.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.41%. For the same industry, the average monthly price growth was +5.97%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

ATRA is expected to report earnings on May 08, 2024.

XNCR is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+4.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ATRA with price predictions.
OPEN
A.I.dvisor published
a Summary for XNCR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
XNCR($1.37B) has a higher market cap than ATRA($71.3M). ATRA YTD gains are higher at: 36.505 vs. XNCR (5.652). XNCR has higher annual earnings (EBITDA): -127.14M vs. ATRA (-333.73M). XNCR has more cash in the bank: 594M vs. ATRA (102M). ATRA has less debt than XNCR: ATRA (61.8M) vs XNCR (83.4M). XNCR has higher revenues than ATRA: XNCR (168M) vs ATRA (4.54M).
ATRAXNCRATRA / XNCR
Capitalization71.3M1.37B5%
EBITDA-333.73M-127.14M262%
Gain YTD36.5055.652646%
P/E RatioN/A72.46-
Revenue4.54M168M3%
Total Cash102M594M17%
Total Debt61.8M83.4M74%
FUNDAMENTALS RATINGS
ATRA vs XNCR: Fundamental Ratings
ATRA
XNCR
OUTLOOK RATING
1..100
7163
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
6461
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATRA's Valuation (74) in the Biotechnology industry is in the same range as XNCR (79). This means that ATRA’s stock grew similarly to XNCR’s over the last 12 months.

ATRA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as XNCR (100). This means that ATRA’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's SMR Rating (94) in the Biotechnology industry is in the same range as ATRA (100). This means that XNCR’s stock grew similarly to ATRA’s over the last 12 months.

XNCR's Price Growth Rating (61) in the Biotechnology industry is in the same range as ATRA (64). This means that XNCR’s stock grew similarly to ATRA’s over the last 12 months.

XNCR's P/E Growth Rating (7) in the Biotechnology industry is significantly better than the same rating for ATRA (100). This means that XNCR’s stock grew significantly faster than ATRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRAXNCR
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 8 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Ad is loading...
ATRADaily Signal changed days agoGain/Loss if shorted
 
Show more...
XNCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRDSQ0.06N/A
+2.44%
Bird Global
CRRFY3.530.06
+1.73%
Carrefour S A (F)
KHNGY55.240.42
+0.77%
Kuehne & Nagel International Ag Schindellegi
CIBEY1.65-0.05
-2.94%
Commercial International Bank Ltd
MNSEF0.02N/A
-3.43%
Magnis Energy Technologies Ltd

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+4.18%
BEAM - XNCR
54%
Loosely correlated
+2.35%
PRME - XNCR
53%
Loosely correlated
+1.65%
VCYT - XNCR
52%
Loosely correlated
+2.65%
DNLI - XNCR
52%
Loosely correlated
+4.48%
NTLA - XNCR
51%
Loosely correlated
+2.82%
More